Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy
出版年份 2011 全文链接
标题
Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 12, Issue 3, Pages 423-432
出版商
Future Medicine Ltd
发表日期
2011-03-30
DOI
10.2217/pgs.10.190
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular Profiling of Glatiramer Acetate Early Treatment Effects in Multiple Sclerosis
- (2013) Anat Achiron et al. DISEASE MARKERS
- Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma
- (2010) F. Morschhauser et al. ANNALS OF ONCOLOGY
- A Genomic Approach to Human Autoimmune Diseases
- (2010) Virginia Pascual et al. Annual Review of Immunology
- Clinical Effect of Neutralizing Antibodies to Interferon Beta That Persist Long After Cessation of Therapy for Multiple Sclerosis
- (2010) Laura F. van der Voort ARCHIVES OF NEUROLOGY
- The blood–brain barrier, chemokines and multiple sclerosis
- (2010) David W. Holman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Overlapping and distinct mechanisms of action of multiple sclerosis therapies
- (2010) J.J. Graber et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis?
- (2010) D. Hesse et al. EUROPEAN JOURNAL OF NEUROLOGY
- Molecular oracles for multiple sclerosis therapy
- (2010) Hartmut Wekerle et al. NATURE MEDICINE
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- Breakthrough disease during interferon- therapy in MS: No signs of impaired biologic response
- (2010) D. Hesse et al. NEUROLOGY
- Cross-sectional study assessing long-term safety of interferon- -1b for relapsing-remitting MS
- (2010) A. T. Reder et al. NEUROLOGY
- Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-β-1b treatment in relapsing remitting MS
- (2010) Robert H Goertsches et al. PHARMACOGENOMICS
- Novel Approaches to Detect Serum Biomarkers for Clinical Response to Interferon-β Treatment in Multiple Sclerosis
- (2010) Kaushal S. Gandhi et al. PLoS One
- Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis
- (2010) Orhan Aktas et al. TRENDS IN NEUROSCIENCES
- T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-β
- (2009) Luca Durelli et al. ANNALS OF NEUROLOGY
- Systems biology and its application to the understanding of neurological diseases
- (2009) Pablo Villoslada et al. ANNALS OF NEUROLOGY
- Genome-wide Scan of 500 000 Single-Nucleotide Polymorphisms Among Responders and Nonresponders to Interferon Beta Therapy in Multiple Sclerosis
- (2009) Manuel Comabella et al. ARCHIVES OF NEUROLOGY
- Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells
- (2009) Michael Gurevich et al. BMC Medical Genomics
- A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
- (2009) M. Comabella et al. BRAIN
- ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis
- (2009) S. Cotte et al. BRAIN
- Identification of new sensitive biomarkers for thein vivoresponse to interferon-β treatment in multiple sclerosis using DNA-array evaluation
- (2009) F. Sellebjerg et al. EUROPEAN JOURNAL OF NEUROLOGY
- IFN- Inhibits Human Th17 Cell Differentiation
- (2009) V. S. Ramgolam et al. JOURNAL OF IMMUNOLOGY
- Role of the innate immune system in the pathogenesis of multiple sclerosis
- (2009) Roopali Gandhi et al. JOURNAL OF NEUROIMMUNOLOGY
- Monitoring of multiple sclerosis immunotherapy
- (2009) Robert H. Goertsches et al. JOURNAL OF NEUROLOGY
- Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis
- (2009) Richard A Rudick et al. LANCET NEUROLOGY
- Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit
- (2009) WM Carroll Multiple Sclerosis Journal
- MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis
- (2009) Changsheng Du et al. NATURE IMMUNOLOGY
- Predicting responders to therapies for multiple sclerosis
- (2009) Jordi Río et al. Nature Reviews Neurology
- Absence of MxA induction by interferon in patients with MS reflects complete loss of bioactivity
- (2009) D. Hesse et al. NEUROLOGY
- The mechanism of action of glatiramer acetate treatment in multiple sclerosis
- (2009) M. K. Racke et al. NEUROLOGY
- Interferon- mechanisms of action in multiple sclerosis
- (2009) S. Dhib-Jalbut et al. NEUROLOGY
- United Europeans for development of pharmacogenomics in multiple sclerosis network
- (2009) Koen Vandenbroeck et al. PHARMACOGENOMICS
- Genetic polymorphisms, their allele combinations and IFN-β treatment response in Irish multiple sclerosis patients
- (2009) Catherine O’Doherty et al. PHARMACOGENOMICS
- Longitudinal system-based analysis of transcriptional responses to type I interferons
- (2009) D. J. Pappas et al. PHYSIOLOGICAL GENOMICS
- Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple Sclerosis
- (2008) Esther Byun et al. ARCHIVES OF NEUROLOGY
- Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
- (2008) M. Krumbholz et al. BRAIN
- BAFF is a Biological Response Marker to IFN-β Treatment in Multiple Sclerosis
- (2008) Kaushal S. Gandhi et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- IFN-β1b Induces Transient and Variable Gene Expression in Relapsing-Remitting Multiple Sclerosis Patients Independent of Neutralizing Antibodies or Changes in IFN Receptor RNA Expression
- (2008) Anthony T. Reder et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Genomic effects of once-weekly, intramuscular interferon-β1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients
- (2008) Bianca Weinstock-Guttman et al. JOURNAL OF NEUROIMMUNOLOGY
- IFN-β-regulated genes show abnormal expression in therapy-naïve relapsing–remitting MS mononuclear cells: Gene expression analysis employing all reported protein–protein interactions
- (2008) Ken D. Yamaguchi et al. JOURNAL OF NEUROIMMUNOLOGY
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Gene expression analysis of interferon-β treatment in multiple sclerosis
- (2008) F Sellebjerg et al. Multiple Sclerosis Journal
- The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
- (2008) Jorge R. Oksenberg et al. NATURE REVIEWS GENETICS
- Pharmacogenomics of IFN-β in multiple sclerosis: towards a personalized medicine approach
- (2008) Saskia Vosslamber et al. PHARMACOGENOMICS
- Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
- (2008) Lisa G. M. van Baarsen et al. PLoS One
- A Global View of Gene Activity and Alternative Splicing by Deep Sequencing of the Human Transcriptome
- (2008) M. Sultan et al. SCIENCE
- Interleukin-17: A novel inflammatory cytokine that bridges innate and adaptive immunity
- (2007) Jeffrey et al. Frontiers in Bioscience-Landmark
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started